Use of Peptide Thrombopoietin Receptor Agonist Romiplostim (Nplate) in a Case of Primary HIV-Associated Thrombocytopenia

We describe novel and effective treatment of PHAT with the peptide thrombopoietin receptor agonist romiplostim in a patient with a minimal response to conventional therapy.

http://jia.sagepub.com/cgi/content/abstract/13/1/22?rss=1

Source: Journal of the International Association of Physicians in AIDS Care (JIAPAC) - January 22, 2014 Category: Infectious Diseases Authors: Aslam, M. I., Cardile, A. P., Crawford, G. E. Tags: Case Reports Source Type: research